Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 56 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Vascular cognitive impairment defines alterations in cognition, ranging from subtle deficits to full-blown dementia, attributable to cerebrovascular causes. Often coexisting with Alzheimer's disease, mixed vascular and neurodegenerative dementia has emerged as the leading cause of age-related cognitive impairment. Central to the disease mechanism is the crucial role that cerebral blood vessels play in brain health, not only for the delivery of oxygen and nutrients, but also for the trophic signaling that inextricably links the well-being of neurons and glia to that of cerebrovascular cells. This review will examine how vascular damage disrupts these vital homeostatic interactions, focusing on the hemispheric white matter, a region at heightened risk for vascular damage, and on the interplay between vascular factors and Alzheimer's disease. Finally, preventative and therapeutic prospects will be examined, highlighting the importance of midlife vascular risk factor control in the prevention of late-life dementia.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Iadecola, C. (2013). The pathobiology of vascular dementia. Neuron. https://doi.org/10.1016/j.neuron.2013.10.008

Vancouver

Iadecola C. The pathobiology of vascular dementia. Neuron. 2013. doi:10.1016/j.neuron.2013.10.008. PMID: 24267647.

BibTeX

@article{iadecola2013-24267647,
  author  = {Iadecola, C.},
  title   = {{The pathobiology of vascular dementia}},
  journal = {Neuron},
  year    = {2013},
  doi     = {10.1016/j.neuron.2013.10.008},
  pmid    = {24267647},
  url     = {https://doi.org/10.1016/j.neuron.2013.10.008}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This narrative review defines vascular cognitive impairment as changes in thinking "attributable to cerebrovascular causes", from subtle deficits to dementia. It notes that vascular damage often coexists with Alzheimer's disease. It sets out to examine how damaged blood vessels disrupt their support of nerve and glial cells, especially in the brain's white matter, and it highlights "the importance of midlife vascular risk factor control in the prevention of late-life dementia." It is an expert review, not a trial, so that prevention point is the author's emphasis rather than a tested result.

Study details

How this study scored 56/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 7 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 4 of 6; Still being cited 4 of 4; Senior author's track record 4 of 4; Institution's track record 1 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 56 of 100.56 of 100 points earned44 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neuron)
Journal's citation record 4 / 4 Neuron: journal h-index 689 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2013 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 7 / 7 Cited 1,852 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 123.5 citations a year over 15 year(s) since 2013
Impact for its field and year 6 / 6 Cited 42.4× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 4 / 6 Cited by 69 other studies in this library
Still being cited 4 / 4 Cited 511 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Costantino Iadecola: h-index 128 (OpenAlex, whole career)
Institution's track record 1 / 3 Weill Cornell Medicine: institution h-index 1,163 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 24267647)
Free to read 0 / 2 Behind a paywall — scores zero
Total 56 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 43.

Later studies that cite this one

69 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Prevention and risk

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →